Treatment of Sarcoidosis With Infliximab

This publication has 25 references indexed in Scilit:

• Tumour necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients
  Annals of the Rheumatic Diseases, 2004
• Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
  New England Journal of Medicine, 2003
• Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration
  Arthritis & Rheumatism, 2002
• Ocular Manifestations of Sarcoidosis
  Seminars in Respiratory and Critical Care Medicine, 2002
• Sarcoidosis of the Thyroid and Kidneys and Calcium Metabolism
  Seminars in Respiratory and Critical Care Medicine, 2002
• Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
  New England Journal of Medicine, 2001
• TREATMENT WITH CORTICOSTEROIDS
  Clinics in Chest Medicine, 1997
• Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis.
  American Journal of Respiratory and Critical Care Medicine, 1995
• The Use of Low Dose Methotrexate in Refractory Sarcoidosis
  The Lancet Healthy Longevity, 1990
• The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
  Cell, 1989